- Department
- CMC
- Employment Type
- Full Time
- Location
- The Netherlands
- Workplace type
- Onsite
Your role
Your profile
Our offer
About Merus
Merus is developing best-in-class therapeutics to treat and potentially cure cancer patients. Our most advanced development programs use the Biclonics format. Biclonics are capable of simultaneously attacking tumors in multiple ways. For example by activating the immune system to kill tumor cells and directly inhibiting tumor cell growth and survival pathways.
Working at Merus offers opportunity to grow and develop a career that offers both individual and company success. You have the chance to make an impact within the oncology field by being part of the development of bispecific antibody therapies (Biclonics) to help fight cancer. Merus Head Quarters are located in The Netherlands with offices in the US and collaborators around the world. As of 2016 we are listed on NASDAQ and over a period of 10 years we have several candidate drugs in clinical trials. For more information please visit
Required Experience:
Director
DepartmentCMCEmployment TypeFull TimeLocationThe NetherlandsWorkplace typeOnsite Your role Your profile Our offer About Merus Merus is developing best-in-class therapeutics to treat and potentially cure cancer patients. Our most advanced dev...
- Department
- CMC
- Employment Type
- Full Time
- Location
- The Netherlands
- Workplace type
- Onsite
Your role
Your profile
Our offer
About Merus
Merus is developing best-in-class therapeutics to treat and potentially cure cancer patients. Our most advanced development programs use the Biclonics format. Biclonics are capable of simultaneously attacking tumors in multiple ways. For example by activating the immune system to kill tumor cells and directly inhibiting tumor cell growth and survival pathways.
Working at Merus offers opportunity to grow and develop a career that offers both individual and company success. You have the chance to make an impact within the oncology field by being part of the development of bispecific antibody therapies (Biclonics) to help fight cancer. Merus Head Quarters are located in The Netherlands with offices in the US and collaborators around the world. As of 2016 we are listed on NASDAQ and over a period of 10 years we have several candidate drugs in clinical trials. For more information please visit
Required Experience:
Director
View more
View less